BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Methylation as a biomarker for head and neck cancer. Oral Oncol 2014;50:587-92. [PMID: 24656975 DOI: 10.1016/j.oraloncology.2014.02.015] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 B Mali S. Epigenetics: Promising journey so far but ways to go in head neck cancer. Oral Oncology 2022;135:106194. [DOI: 10.1016/j.oraloncology.2022.106194] [Reference Citation Analysis]
2 Ishikawa R, Imai A, Mima M, Yamada S, Takeuchi K, Mochizuki D, Shinmura D, Kita J, Nakagawa T, Kurokawa T, Misawa Y, Nakanishi H, Takizawa Y, Misawa K. Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer. Current Problems in Cancer 2022. [DOI: 10.1016/j.currproblcancer.2021.100834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mutlu M, Mutlu P, Azarkan S, Bayır Ö, Öcal B, Saylam G, Korkmaz MH. Evaluation of Methylation Profiles of An Epidermal Growth Factor Receptor Gene in a Head and Neck Squamous Cell Carcinoma Patient Group. Balkan J Med Genet 2020;23:65-72. [PMID: 33816074 DOI: 10.2478/bjmg-2020-0025] [Reference Citation Analysis]
4 Jin Y, Qin X. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma. Biosci Rep 2020;40:BSR20193349. [PMID: 31894857 DOI: 10.1042/BSR20193349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kanakamani S, Suresh PS, Venkatesh T. Regulation of processing bodies: From viruses to cancer epigenetic machinery. Cell Biol Int 2021;45:708-19. [PMID: 33325125 DOI: 10.1002/cbin.11527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Xia Y, Wang Q, Huang X, Yin X, Song J, Ke Z, Duan X. miRNA-Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma. Biomed Res Int 2020;2020:1686480. [PMID: 33490233 DOI: 10.1155/2020/1686480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Feng Y, Jiang Y, Feng Q, Xu L, Jiang Y, Meng F, Shu X. A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature. Cancer Biol Ther 2020;21:1119-27. [PMID: 33151129 DOI: 10.1080/15384047.2020.1833811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Lena PD, Sala C, Prodi A, Nardini C. Methylation data imputation performances under different representations and missingness patterns. BMC Bioinformatics 2020;21:268. [PMID: 32600298 DOI: 10.1186/s12859-020-03592-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Madhura MG, Rao RS, Patil S, Fageeh HN, Alhazmi A, Awan KH. Advanced diagnostic aids for oral cancer. Dis Mon 2020;66:101034. [PMID: 32594996 DOI: 10.1016/j.disamonth.2020.101034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
10 Liu DM, Yang H, Yuan ZN, Yang XG, Pei R, He HJ. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression. Biochem Biophys Res Commun 2020;529:148-55. [PMID: 32703403 DOI: 10.1016/j.bbrc.2020.05.178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Mao YK, Liu ZB, Cai L. Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression. Oncol Lett 2020;20:1619-28. [PMID: 32724403 DOI: 10.3892/ol.2020.11729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 González-Pérez LV, Isaza-Guzmán DM, Arango-Pérez EA, Tobón-Arroyave SI. Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population. J Clin Exp Dent 2020;12:e452-60. [PMID: 32509227 DOI: 10.4317/jced.56647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Pérez-sayáns M, Chamorro-petronacci CM, Gándara-vila P, Lorenzo-pouso AI. Salivary Markers in Systemic and Oral Cancer. Saliva in Health and Disease 2020. [DOI: 10.1007/978-3-030-37681-9_12] [Reference Citation Analysis]
14 Song J, Deng Z, Su J, Yuan D, Liu J, Zhu J. Patterns of Immune Infiltration in HNC and Their Clinical Implications: A Gene Expression-Based Study. Front Oncol 2019;9:1285. [PMID: 31867268 DOI: 10.3389/fonc.2019.01285] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
15 Carr O, Raymundo-Pereira PA, Shimizu FM, Sorroche BP, Melendez ME, de Oliveira Pedro R, Miranda PB, Carvalho AL, Reis RM, Arantes LMRB, Oliveira ON Jr. Genosensor made with a self-assembled monolayer matrix to detect MGMT gene methylation in head and neck cancer cell lines. Talanta 2020;210:120609. [PMID: 31987176 DOI: 10.1016/j.talanta.2019.120609] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
16 Usman M, Ilyas A, Hashim Z, Zarina S. Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach. Pathol Oncol Res 2020;26:1817-22. [PMID: 31748878 DOI: 10.1007/s12253-019-00775-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Gaździcka J, Gołąbek K, Strzelczyk JK, Ostrowska Z. Epigenetic Modifications in Head and Neck Cancer. Biochem Genet 2020;58:213-44. [PMID: 31712935 DOI: 10.1007/s10528-019-09941-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
18 Lin D, Wu Q, Qiu S, Chen G, Feng S, Chen R, Zeng H. Label-free liquid biopsy based on blood circulating DNA detection using SERS-based nanotechnology for nasopharyngeal cancer screening. Nanomedicine 2019;22:102100. [PMID: 31648038 DOI: 10.1016/j.nano.2019.102100] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
19 Liang Y, Song J, He D, Xia Y, Wu Y, Yin X, Liu J. Systematic analysis of survival-associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer. J Cell Physiol 2019;234:15836-46. [PMID: 30740675 DOI: 10.1002/jcp.28241] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
20 Kim SY, Han YK, Song JM, Lee CH, Kang K, Yi JM, Park HR. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC). Clin Epigenetics 2019;11:116. [PMID: 31405379 DOI: 10.1186/s13148-019-0715-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
21 Kaczor-Urbanowicz KE, Wei F, Rao SL, Kim J, Shin H, Cheng J, Tu M, Wong DTW, Kim Y. Clinical validity of saliva and novel technology for cancer detection. Biochim Biophys Acta Rev Cancer 2019;1872:49-59. [PMID: 31152821 DOI: 10.1016/j.bbcan.2019.05.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 9.5] [Reference Citation Analysis]
22 Bai G, Song J, Yuan Y, Chen Z, Tian Y, Yin X, Niu Y, Liu J. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer. J Cell Physiol 2019;234:22687-702. [PMID: 31131446 DOI: 10.1002/jcp.28835] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
23 Gomes CC, Diniz MG, Gomez RS. The Molecular Basis of Carcinogenesis. In: Brennan PA, Aldridge T, Dwivedi RC, editors. Premalignant Conditions of the Oral Cavity. Singapore: Springer; 2019. pp. 7-26. [DOI: 10.1007/978-981-13-2931-9_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Wang YH, Yin YW, Zhou H, Cao YD. miR-639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma. Oncol Lett 2018;16:6903-9. [PMID: 30546422 DOI: 10.3892/ol.2018.9512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
25 Carta CFL, Oliveira Alves MG, de Barros PP, Campos MS, Scholz J, Jorge AOC, Nunes FD, Almeida JD. Screening methylation of DNA repair genes in the oral mucosa of chronic smokers. Archives of Oral Biology 2018;92:83-7. [DOI: 10.1016/j.archoralbio.2018.04.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Götz C, Bissinger O, Nobis C, Wolff KD, Drecoll E, Kolk A. ALDH1 as a prognostic marker for lymph node metastasis in OSCC. Biomed Rep 2018;9:284-90. [PMID: 30233780 DOI: 10.3892/br.2018.1131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Zhou C, Li J, Li Q. CDKN2A methylation in esophageal cancer: a meta-analysis. Oncotarget. 2017;8:50071-50083. [PMID: 28637022 DOI: 10.18632/oncotarget.18412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
28 Misawa K, Imai A, Mochizuki D, Mima M, Endo S, Misawa Y, Kanazawa T, Mineta H. Association of TET3 epigenetic inactivation with head and neck cancer. Oncotarget 2018;9:24480-93. [PMID: 29849955 DOI: 10.18632/oncotarget.25333] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
29 Gong W, Xiao Y, Wei Z, Yuan Y, Qiu M, Sun C, Zeng X, Liang X, Feng M, Chen Q. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma. Oncotarget 2017;8:2141-52. [PMID: 27924064 DOI: 10.18632/oncotarget.13798] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
30 Pereira CM, de Carvalho AC, da Silva FR, Melendez ME, Lessa RC, Andrade VCC, Kowalski LP, Vettore AL, Carvalho AL. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer. BMC Cancer 2018;18:193. [PMID: 29454310 DOI: 10.1186/s12885-018-4077-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
31 Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C. Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance. Onco Targets Ther 2018;11:651-63. [PMID: 29440913 DOI: 10.2147/OTT.S154999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
32 Misawa K, Mochizuki D, Imai A, Mima M, Misawa Y, Mineta H. Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis. Cancers (Basel) 2018;10:E27. [PMID: 29361757 DOI: 10.3390/cancers10010027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
33 Peri S, Andrews AJ, Bhatia A, Mehra R. Epigenetic Changes and Epigenetic Targets in Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer 2018. [DOI: 10.1007/978-3-319-78762-6_12] [Reference Citation Analysis]
34 Dumitrescu RG. Alcohol-Induced Epigenetic Changes in Cancer. Methods Mol Biol 2018;1856:157-72. [PMID: 30178251 DOI: 10.1007/978-1-4939-8751-1_9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
35 Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn 2018;18:85-112. [PMID: 29134827 DOI: 10.1080/14737159.2017.1404906] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
36 Li J, Zhou C, Wang G, Wang S, Ni S, Ye M, Zhang J. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma. Gene 2018;644:74-9. [PMID: 29107007 DOI: 10.1016/j.gene.2017.10.059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
37 Wan Y, Vagenas D, Salazar C, Kenny L, Perry C, Calvopiña D, Punyadeera C. Salivary miRNA panel to detect HPV-positive and HPV-negative head and neck cancer patients. Oncotarget 2017;8:99990-100001. [PMID: 29245955 DOI: 10.18632/oncotarget.21725] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
38 Shen S, Wang G, Shi Q, Zhang R, Zhao Y, Wei Y, Chen F, Christiani DC. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma. Clin Epigenetics 2017;9:88. [PMID: 28852427 DOI: 10.1186/s13148-017-0392-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
39 Misawa K, Imai A, Mochizuki D, Misawa Y, Endo S, Hosokawa S, Ishikawa R, Mima M, Shinmura K, Kanazawa T, Mineta H. Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis. Oncotarget 2017;8:76318-28. [PMID: 29100314 DOI: 10.18632/oncotarget.19356] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
40 Castilho RM, Squarize CH, Almeida LO. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy. Int J Mol Sci 2017;18:E1506. [PMID: 28704968 DOI: 10.3390/ijms18071506] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 15.2] [Reference Citation Analysis]
41 van Ginkel JH, Huibers MMH, van Es RJJ, de Bree R, Willems SM. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients. BMC Cancer 2017;17:428. [PMID: 28629339 DOI: 10.1186/s12885-017-3424-0] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]
42 Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ. Methylation markers differentiate thyroid cancer from benign nodules. J Endocrinol Invest. 2018;41:163-170. [PMID: 28612287 DOI: 10.1007/s40618-017-0702-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
43 Burassakarn A, Pientong C, Sunthamala N, Chuerduangphui J, Vatanasapt P, Patarapadungkit N, Kongyingyoes B, Ekalaksananan T. Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein–Barr virus-associated oral squamous cell carcinomas. Med Oncol 2017;34. [DOI: 10.1007/s12032-017-0983-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
44 Shaw RJ, Brown J, Ettl T, Risk JM. Prognostic Factors in Oral, Oropharyngeal, and Salivary Gland Cancer. Maxillofacial Surgery 2017. [DOI: 10.1016/b978-0-7020-6056-4.00015-0] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Ribeiro IP, Barroso L, Marques F, Melo JB, Carreira IM. Early detection and personalized treatment in oral cancer: the impact of omics approaches. Mol Cytogenet 2016;9:85. [PMID: 27895714 DOI: 10.1186/s13039-016-0293-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
46 Misawa K, Mochizuki D, Endo S, Mima M, Misawa Y, Imai A, Shinmura K, Kanazawa T, Carey TE, Mineta H. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis: METHYLATION PATTERNS OF THE GAL AND GALR1/2 GENES. Mol Carcinog 2017;56:1107-16. [DOI: 10.1002/mc.22577] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
47 Shen Z, Zhou C, Li J, Deng H, Li Q, Wang J. The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies. Onco Targets Ther 2016;9:6763-73. [PMID: 27826202 DOI: 10.2147/OTT.S117453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
48 Lim Y, Wan Y, Vagenas D, Ovchinnikov DA, Perry CF, Davis MJ, Punyadeera C. Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers. BMC Cancer 2016;16:749. [PMID: 27663357 DOI: 10.1186/s12885-016-2785-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
49 Clausen MJ, Melchers LJ, Mastik MF, Slagter-Menkema L, Groen HJ, Laan BF, van Criekinge W, de Meyer T, Denil S, van der Vegt B, Wisman GB, Roodenburg JL, Schuuring E. RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis. Epigenetics 2016;11:653-63. [PMID: 27379752 DOI: 10.1080/15592294.2016.1205176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
50 Abe M, Yamashita S, Mori Y, Abe T, Saijo H, Hoshi K, Ushijima T, Takato T. High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes. BMC Cancer 2016;16:350. [PMID: 27255271 DOI: 10.1186/s12885-016-2371-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
51 Singh NN, Peer A, Nair S, Chaturvedi RK. Epigenetics: A possible answer to the undeciphered etiopathogenesis and behavior of oral lesions. J Oral Maxillofac Pathol 2016;20:122-8. [PMID: 27194874 DOI: 10.4103/0973-029X.180967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
52 Lim Y, Sun CX, Tran P, Punyadeera C. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas. Biomarkers in Medicine 2016;10:301-13. [DOI: 10.2217/bmm.16.2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
53 Mishra S, Saadat D, Kwon O, Lee Y, Choi WS, Kim JH, Yeo WH. Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics. Biosens Bioelectron 2016;81:181-97. [PMID: 26946257 DOI: 10.1016/j.bios.2016.02.040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
54 Meng RW, Li YC, Chen X, Huang YX, Shi H, Du DD, Niu X, Lu C, Lu MX. Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-Analysis. Sci Rep 2016;6:20756. [PMID: 26857374 DOI: 10.1038/srep20756] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
55 Yamaguchi A, Kuroyama K, Tokura A, Saito A, Arikawa H, Hasebe T, Usui D, Yamaguchi K, Chiba T, Imai K. Krüppel-like factor 4 expression in oral carcinoma cells and hypermethylation at the gene promoter. BMC Oral Health 2016;16:13. [PMID: 26847634 DOI: 10.1186/s12903-016-0172-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Kostareli E, Hielscher T, Zucknick M, Baboci L, Wichmann G, Holzinger D, Mücke O, Pawlita M, Del Mistro A, Boscolo-Rizzo P, Da Mosto MC, Tirelli G, Plinkert P, Dietz A, Plass C, Weichenhan D, Hess J. Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics 2016;11:61-73. [PMID: 26786582 DOI: 10.1080/15592294.2015.1137414] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
57 Tarantino G, Finelli C. Lipids, Low-Grade Chronic Inflammation and NAFLD. Handbook of Lipids in Human Function 2016. [DOI: 10.1016/b978-1-63067-036-8.00028-7] [Reference Citation Analysis]
58 Tarantino G, Finelli C. Lipids Nutrition and Epigenetic Modification in Obesity-Related Co-Morbitities * *All authors equally contributed to draft the manuscript. All authors gave final approval of the version to be published. Disclosure statement: The authors declare that there are no conflicts of interest. Handbook of Lipids in Human Function 2016. [DOI: 10.1016/b978-1-63067-036-8.00004-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
59 Gaykalova DA, Vatapalli R, Wei Y, Tsai HL, Wang H, Zhang C, Hennessey PT, Guo T, Tan M, Li R, Ahn J, Khan Z, Westra WH, Bishop JA, Zaboli D, Koch WM, Khan T, Ochs MF, Califano JA. Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients. PLoS One 2015;10:e0142148. [PMID: 26544568 DOI: 10.1371/journal.pone.0142148] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
60 Virani S, Bellile E, Bradford CR, Carey TE, Chepeha DB, Colacino JA, Helman JI, McHugh JB, Peterson LA, Sartor MA, Taylor JM, Walline HM, Wolf GT, Rozek LS. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas. BMC Cancer 2015;15:825. [PMID: 26518708 DOI: 10.1186/s12885-015-1806-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
61 Puram SV, Rocco JW. Molecular Aspects of Head and Neck Cancer Therapy. Hematol Oncol Clin North Am 2015;29:971-92. [PMID: 26568543 DOI: 10.1016/j.hoc.2015.07.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
62 Clausen MJ, Melchers LJ, Mastik MF, Slagter-Menkema L, Groen HJ, van der Laan BF, van Criekinge W, de Meyer T, Denil S, Wisman GB, Roodenburg JL, Schuuring E. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma. Genes Chromosomes Cancer 2016;55:45-59. [PMID: 26391330 DOI: 10.1002/gcc.22310] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
63 Ajona D, Pajares M, Chiara M, Rodrigo J, Jantus-lewintre E, Camps C, Suarez C, Bagán J, Montuenga L, Pio R. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma. Oral Dis 2015;21:899-904. [DOI: 10.1111/odi.12363] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
64 Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN Jr, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev Res (Phila) 2015;8:1027-35. [PMID: 26342026 DOI: 10.1158/1940-6207.CAPR-14-0179] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
65 Choudhury JH, Ghosh SK. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics. PLoS One 2015;10:e0129808. [PMID: 26098903 DOI: 10.1371/journal.pone.0129808] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
66 Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma. Tumor Biol 2015;36:7849-58. [DOI: 10.1007/s13277-015-3504-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
67 Chauhan SS, Kaur J, Kumar M, Matta A, Srivastava G, Alyass A, Assi J, Leong I, MacMillan C, Witterick I, Colgan TJ, Shukla NK, Thakar A, Sharma MC, Siu KW, Walfish PG, Ralhan R. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis 2015;4:e147. [PMID: 25893634 DOI: 10.1038/oncsis.2015.7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
68 Arantes L, de Carvalho A, Melendez M, Centrone C, Góis-filho J, Toporcov T, Caly D, Tajara E, Goloni-bertollo E, Carvalho A. Validation of methylation markers for diagnosis of oral cavity cancer. European Journal of Cancer 2015;51:632-41. [DOI: 10.1016/j.ejca.2015.01.060] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
69 Ohshima H. Oral Biosciences: The annual review 2014. Journal of Oral Biosciences 2015;57:1-8. [DOI: 10.1016/j.job.2014.12.002] [Reference Citation Analysis]
70 Koffler J, Sharma S, Hess J. Predictive value of epigenetic alterations in head and neck squamous cell carcinoma. Mol Cell Oncol 2014;1:e954827. [PMID: 27308324 DOI: 10.1080/23723548.2014.954827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
71 Asokan GS, Jeelani S, Gnanasundaram N. Promoter hypermethylation profile of tumour suppressor genes in oral leukoplakia and oral squamous cell carcinoma. J Clin Diagn Res 2014;8:ZC09-12. [PMID: 25478438 DOI: 10.7860/JCDR/2014/9251.4949] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
72 Li KC, Hua KT, Lin YS, Su CY, Ko JY, Hsiao M, Kuo ML, Tan CT. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma. Mol Cancer 2014;13:172. [PMID: 25027955 DOI: 10.1186/1476-4598-13-172] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
73 Bhatia V, Goel MM, Makker A, Tewari S, Yadu A, Shilpi P, Kumar S, Agarwal SP, Goel SK. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma. Biomed Res Int 2014;2014:248419. [PMID: 24991542 DOI: 10.1155/2014/248419] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]